共查询到17条相似文献,搜索用时 140 毫秒
1.
2.
动物乳腺生物反应器的现状和趋势 总被引:19,自引:1,他引:19
利用转基因家畜的乳腺生产人类重组蛋白,可以高效获得安全、足量的药用蛋白。本文针对乳腺生物反应器的成功研制,从目的基因的选择、载体构建、转基因技术等方面探讨了动物乳腺生物反应器的研究现状。分析了提高转基因效率和外源蛋白表达水平的技术途径,提出了降低总体成本的战略措施。特别探讨了利用Cre-loxP系统发展“体细胞打靶体细胞核移植技术体系”,高效生产乳腺生物反应器动物的可能性。 相似文献
3.
体细胞基因打靶制备动物乳腺生物反应器的策略与应用 总被引:8,自引:2,他引:8
在转基因动物研究中,由于基因表达调控元件的人工拼接和外源基因在动物基因组中随机整合所带来的“位置效应”,致使转基因动物外源基因的表达水平不高并且差异较大。为此,利用定位整合优势,对以基因同源重组为基础的基因打靶技术进行了大量研究。介绍了就利用体细胞基因打靶和核移植技术制备动物乳腺生物反应器的策略和应用情况做一综述,并对提高基因打靶效率的各种策略,打靶细胞的选择,转基因细胞核移植的低融合事件以及基因打靶制备乳腺生物反应器的优越性进行分析。 相似文献
4.
动物乳腺生物反应器的研究进展 总被引:4,自引:0,他引:4
张振龙 《微生物学免疫学进展》2000,28(4):85-89
利用转基因动物反应器生产药用蛋白是生物技术领域的一次革命,而通过动物乳腺是最好的渠道,药物蛋白可通过转基因动物的乳腺随乳汁分泌出来,产量高、易纯化,因此乳腺类似于一个制药工厂。国外已有多种蛋白通过乳朱反应器来制备,有些已进入临床研究阶段。本文主要介绍乳腺生物反应器的研究进展情况。 相似文献
5.
核移植技术生产乳腺生物反应器的研究进展 总被引:3,自引:0,他引:3
乳腺生物反应器的研制带来了转基因制药业的兴起。但十几年来,显微注射技术一直是生产乳腺生物反应器的唯一实用手段,由于它本身固有的缺点,使得乳腺生物反应器未能有长足的进步。基因打靶与核移植相结合很可能成为生产乳腺生物反应器更有效的途径,它在外源基因定点整合,消除位点效应、降低生产成本、节省时间方面具有明显的优势。 相似文献
6.
转基因技术在制备动物乳腺生物反应器中的应用和发展 总被引:4,自引:0,他引:4
利用乳腺生物反应器可以高效获得安全、足量的药用蛋白,在制药工业中具有广阔的应用前景。但是,目前采用的转基因技术由于其各自固有的局限性,未能使乳腺生物反应器的研究取得长足的进步。基因打靶技术和核移植技术的发展为乳腺生物反应器的开发注入了新的活力。本文综合近年来国内外文献,阐述了各种转基因技术的优点与缺陷,同时说明了构建“体细胞打靶-克隆技术体系”在制备大动物的乳腺生物反应器中的必要性。 相似文献
7.
转基因动物乳腺生物反应器的发展概况及人工染色体在其中的应用 总被引:1,自引:0,他引:1
转基因动物乳腺生物反应器位点效应的影响是制备转基因动物乳腺生物反应器过程中的主要问题。酵母人工染色体(YAC)和细菌人工染色体(BAC)具有容量大的特性,可以将乳蛋白的整个基因座包括所有调控序列全部装载进去,有可能克服位点效应的影响,是一种理想的载体。YAC和BAC载体转基因技术可能成为避开基因打靶获得高效表达的转基因动物乳腺生物反应器的另一途径. 相似文献
8.
利用动物乳腺生物反应器生产人类所需的药用蛋白,在制药领域展现出了广阔前景。综述了应用动物乳腺生物反应器制药的优越性和应用进展。 相似文献
9.
乳腺生物反应器的研制带来了转基因制药业的兴起。但十几年来,显微注射技术一直是生产乳腺生物反应器的唯一实用手段,由于它本身固有的缺点,使得乳腺生物反应器未能有长足的进步。基因打靶与核移植相结合很可能成为生产乳腺生物反应器更有效的途径,它在外源基因定点整合,消除位点效应、降低生产成本、节省时间方面具有明显的优势。 相似文献
10.
基因打靶方法制备乳腺生物反应器 总被引:4,自引:0,他引:4
基因打靶技术制备乳腺生物反应器,克服了显微注射法的众多缺陷,并随着第一例基因打靶家畜的诞生而成为这一研究领域的热点。本文从制备乳腺生物反应器过程中基因打靶策略、打靶细胞到打靶位点的选择等各个方面,详细分析了其中的技术难点、解决问题的对策、国内外研究进展以及应用前景。 相似文献
11.
Transgenic animal bioreactors 总被引:24,自引:2,他引:22
Houdebine LM 《Transgenic research》2000,9(4-5):305-320
The production of recombinant proteins is one of the major successes of biotechnology. Animal cells are required to synthesize
proteins with the appropriate post-translational modifications. Transgenic animals are being used for this purpose. Milk,
egg white, blood, urine, seminal plasma and silk worm cocoon from transgenic animals are candidates to be the source of recombinant
proteins at an industrial scale. Although the first recombinant protein produced by transgenic animals is expected to be in
the market in 2000, a certain number of technical problems remain to be solved before the various systems are optimized. Although
the generation of transgenic farm animals has become recently easier mainly with the technique of animal cloning using transfected
somatic cells as nuclear donor, this point remains a limitation as far as cost is concerned. Numerous experiments carried
out for the last 15 years have shown that the expression of the transgene is predictable only to a limited extent. This is
clearly due to the fact that the expression vectors are not constructed in an appropriate manner. This undoubtedly comes from
the fact that all the signals contained in genes have not yet been identified. Gene constructions thus result sometime in
poorly functional expression vectors. One possibility consists in using long genomic DNA fragments contained in YAC or BAC
vectors. The other relies on the identification of the major important elements required to obtain a satisfactory transgene
expression. These elements include essentially gene insulators, chromatin openers, matrix attached regions, enhancers and
introns. A certain number of proteins having complex structures (formed by several subunits, being glycosylated, cleaved,
carboxylated...) have been obtained at levels sufficient for an industrial exploitation. In other cases, the mammary cellular
machinery seems insufficient to promote all the post-translational modifications. The addition of genes coding for enzymes
involved in protein maturation has been envisaged and successfully performed in one case. Furin gene expressed specifically
in the mammary gland proved to able to cleave native human protein C with good efficiency. In a certain number of cases, the
recombinant proteins produced in milk have deleterious effects on the mammary gland function or in the animals themselves.
This comes independently from ectopic expression of the transgenes and from the transfer of the recombinant proteins from
milk to blood. One possibility to eliminate or reduce these side-effects may be to use systems inducible by an exogenous molecule
such as tetracycline allowing the transgene to be expressed only during lactation and strictly in the mammary gland. The purification
of recombinant proteins from milk is generally not particularly difficult. This may not be the case, however, when the endogenous
proteins such as serum albumin or antibodies are abundantly present in milk. This problem may be still more crucial if proteins
are produced in blood. Among the biological contaminants potentially present in the recombinant proteins prepared from transgenic
animals, prions are certainly those raising the major concern. The selection of animals chosen to generate transgenics on
one hand and the elimination of the potentially contaminated animals, thanks to recently defined quite sensitive tests may
reduce the risk to an extremely low level. The available techniques to produce pharmaceutical proteins in milk can be used
as well to optimize milk composition of farm animals, to add nutriceuticals in milk and potentially to reduce or even eliminate
some mammary infectious diseases.
This revised version was published online in August 2006 with corrections to the Cover Date. 相似文献
12.
转基因动物技术的研究进展 总被引:12,自引:0,他引:12
转基因动物是其基因组内稳定整合了所导入的外源基因的动物。目前转基因实验动物体系的研究,主要集中在导入方法和提高整合和表达效率两个方面。本文对这两个方面的进展作一综述。
Abstract:Transgenic animals are those whose genome have foreign genes integrated. Nowadays, researches concentrated in the ways of gene transfer and of improving efficiency of integration and expression.The paper has con cluded these two aspects. 相似文献
13.
14.
15.
16.
Poussin K Hayes H Pauloin A Chanat E Fontaine ML Aujean E Sun JS Debey P Devinoy E 《Journal of cellular biochemistry》2005,96(3):611-621
The expression of casein genes is specific to the mammary gland and maximal during lactation. However, among the numerous mammary cell lines described so far, only a few express some casein genes. The regulatory regions of casein genes have been largely described but the mechanisms explaining the mammary specific expression of these genes, and their silencing in most mammary cell lines, have not yet been fully elucidated. To test the hypothesis that the nuclear location of the casein genes may affect their expression, we transfected HC11 mouse mammary cell line with a 100 kb DNA fragment surrounding the rabbit alpha S1 casein gene. We derived stable clones which express or not the transfected rabbit casein gene, in the same cellular context, independently of the number of transgene copies. Metaphase spreads were prepared from the different clones and the transfected genes were localized. Unexpectedly, we observed that in the original HC11 cell line the number of chromosomes per metaphase spread is close to 80, suggesting that HC11 cells have undergone a duplication event, since the mouse karyotype is 2n = 40. In alpha S1 casein expressing cells, the expression level does not clearly correlate with a localization of the transfected DNA proximal to the centromeres or the telomeres. Analysis of the localization of the transfected DNA in nuclear halos allows us to conclude that when expressed, transfected DNA is more closely linked to the nuclear matrix. The next step will be to study the attachment of the endogenous casein gene in mammary nuclei during lactation. 相似文献
17.
现已证明,应用抗体治疗疾病是一种非常成功的方法。单克隆抗体的生产使免疫治疗达到一个新水平,但鼠源单抗在治疗人体疾病方面有很多问题,而人源化抗体可以解决这些问题。目前抗体人源化已由鼠嵌合抗体发展到了转基因动物表达完全人抗体阶段,而人类人工染色体(HAC)载体的发展和微细胞介导的转染色体技术使得产生携带人类免疫球蛋白基因位点的转染色体动物成为可能。通过HAC将人的免疫球蛋白基因转入后,这类转染色体动物可以产生大量人源化多克隆抗体,这对预防及治疗疾病,甚至防御生物武器都有很重要的作用。转染色体技术可以使动物携带大而复杂的人类基因或基因簇,这些转基因动物有助于研究人类基因组在体内的功能作用,并用于各种疾病研究和生产药物蛋白。 相似文献